Quantum Biopharma Ltd. Class B Subordinate Voting Shares (QNTM)
NASDAQ
$3.87−$0.1300 (−3.25%) on the dayAs of the close; data may be delayed.
QNTM price, last 12 months
Key stats
- Previous close
- $4.00
- Open
- $3.94
- Day range
- $3.80 – $4.00
- 52-week range
- $2.07 – $19.30
- Volume
- 188.2K
- Avg volume (20 days)
- 199.1K
- Market cap
- $31.1M
Performance
1W+5.7%
1M+26.1%
3M+1.8%
6M+1.0%
YTD−47.0%
1Y−77.4%
vs S&P 500, 1Y−94.2 pts
Technicals and fundamentals
About Quantum Biopharma Ltd. Class B Subordinate Voting Shares
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
- Listed on
- NASDAQ
- Market cap
- $31.1M